Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
ANI Pharmaceuticals Inc
Swot
ANI Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
ANI Pharmaceuticals Inc has 16 Strengths, 9 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(16)
Weakness
(9)
Opportunity
(0)
Threats
(3)
Others
(0)
Relative Strength Index (RSI) Bullish
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Near 52 Week High
Increasing Revenue every Quarter for the past 4 Quarters
Stock gained more than 20% in one month
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
Momentum Trap (DVM)
Companies with High Debt
Negative profit growth, promoters decreasing shareholding QoQ
PEG greater than Industry PEG
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
